Skip to main content

Table 1 The demographic information and baseline characteristics of all groups

From: The association between thyroid function and insulin resistance as measured by the metabolic score for insulin resistance (METS-IR): insights from NHANES 2007–2012

Variables

Total

Overt hypothyroidism

Subclinical hypothyroidism

Euthyroid

Subclinical hyperthyroidism

Overt

hyperthyroidism

p-value

Number (%)

6507 (100)

21 (0.32)

467 (7.18)

5805 (89.21)

156 (2.40)

58 (0.89)

 

Age, mean (SD)

58.52 (16.30)

65.76 (15.36)

64.83 (14.97)

57.75 (16.29)

62.92 (14.93)

70.59 (13.01)

< 0.001

Gender, N (%)

 Male

3102 (47.67)

12 (57.14)

185 (39.61)

2834 (48.82)

62 (39.74)

9 (15.52)

< 0.001

 Female

3405 (52.33)

9 (42.86)

282 (60.39)

2971 (51.18)

94 (60.26)

49 (84.48)

 1.30–3.49

2333 (35.85)

10 (47.62)

251 (53.75)

1975 (34.00)

73 (46.80)

24 (41.38)

 ≥ 3.50

2274 (34.95)

9 (42.86)

113 (24.20)

2089 (35.99)

35 (22.44)

28 (48.28)

Smoking, N (%)

 Never smoker

3687 (56.66)

0 (0)

257 (55.03)

3308 (56.98)

92 (58.98)

30 (51.72)

< 0.001

 Past smoker

1293 (19.87)

0 (0)

98 (20.98)

1161 (20.00)

23 (14.74)

11 (18.96)

 Current smoker

1527 (23.47)

21 (100)

112 (23.99)

1336 (23.02)

41 (26.28)

17 (29.31)

BMI (kg/m²), mean (SD)

29.59 (6.71)

31.55 (9.23)

30.49 (7.85)

29.59 (6.65)

28.00 (4.85)

26.48 (4.48)

< 0.001

SBP (mmHg), mean (SD)

129.44 (20.97)

118.57 (23.77)

132.43 (21.76)

129.14 (20.63)

132.07 (26.20)

132.00 (28.06)

< 0.001

DBP (mmHg), mean (SD)

68.38 (14.75)

69.33 (10.15)

67.49 (12.03)

68.70 (14.71)

63.07 (17.53)

57.46 (23.01)

< 0.001

Glucose, plasma (mg/dL), mean (SD)

120.87 (50.82)

118.28 (27.37)

127.47 (55.87)

120.22 (49.69)

130.45 (78.23)

108.36 (12.09)

0.002

Direct HDL-Cholesterol (mg/dL), mean (SD)

53.02 (15.76)

48.19 (10.75)

52.37 (16.32)

53.11 (15.84)

53.20 (12.54)

50.94 (12.95)

< 0.001

Triglyceride (mg/dL), mean (SD)

150.92 (134.98)

177.61 (61.91)

160.29 (91.87)

151.19 (139.72)

124.23 (75.60)

110.87 (41.71)

0.011

METS-IR, mean (SD)

45.14 (12.56)

48.69 (11.25)

47.35 (14.77)

45.09 (12.43)

42.13 (9.95)

39.69 (8.80)

< 0.001

HTN, N (%)

 Yes

3535 (94.34)

20 (100)

251 (92.62)

3124 (94.29)

100 (97.09)

40 (100)

0.003

 No

212 (5.66)

0 (0)

20 (7.38)

189 (5.71)

3 (2.91)

0 (0)

HLP, N (%)

 Yes

2551 (82.05)

0 (0)

130 (75.15)

2324 (82.85)

78 (79.59)

19 (61.29)

< 0.001

 No

558 (17.95)

2 (100)

43 (24.85)

481 (17.15)

20 (20.41)

12 (38.71)

DM, N (%)

 Yes

1784 (27.42)

18 (85.71)

172 (36.83)

1508 (25.99)

64 (41.02)

22 (37.93)

< 0.001

 No

4572 (70.30)

3 (14.29)

292 (62.53)

4150 (71.53)

92 (58.98)

35 (60.34)

 Borderline

148 (2.28)

0 (0)

3 (0.64)

144 (2.48)

0 (0)

1 (1.73)

  1. Comparisons were conducted using weighted analysis of variance (ANOVA) for continuous variables and Rao-Scott chi-square tests for categorical variables. Statistical significance is defined as p < 0.05. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high-density lipoprotein cholesterol, METS-IR metabolic score for insulin resistance, HTN hypertension, HLP hyperlipidemia, DM diabetes mellitus